Working on a slightly distinct model, NCR-based Advancells is looking to carve a niche by thrusting into not the banking of stem cells, but in regenerative medicine. Started by serial entrepreneur Vipul Jain in 2013, Advancells produces stem cells lines, which are then used by its partner hospitals and doctors in providing regenerative therapies to patients. Apart from creating the stem cells that cure diseases, Advancells writes the protocols for medical practitioners on the effective usage of the cells. This has invited the concerns of the Indian Council for Medical Research (ICMR) and the Department of Biotechnology (DBT), making the industry highly regulated. The procedure is performed in a partner hospital using stem cells manufactured in Advancells labs.

Source: dna January 23, 2018 02:12 UTC